Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$686K Buy
8,800
+5,205
+145% +$387K 0.01% 1398
2023
Q4
$257K Sell
3,595
-261
-7% -$18.2K ﹤0.01% 1509
2023
Q3
$268K Buy
+3,856
New +$291K ﹤0.01% 1381
2016
Q3
Sell
-6,860
Closed -$240K 798
2016
Q2
$240K Buy
6,860
+1,000
+17% +$34.6K 0.02% 629
2016
Q1
$205K Hold
5,860
0.02% 630
2015
Q4
$226K Hold
5,860
0.02% 613
2015
Q3
$230K Sell
5,860
-400
-6% -$15.9K 0.02% 567
2015
Q2
$237K Hold
6,260
0.02% 602
2015
Q1
$207K Buy
+6,260
New +$192K 0.02% 627

Other funds holding HOLX

Cetera Advisors's HOLX Position: Q1 2024 in Review

Cetera Advisors increased its Hologic (HOLX) stake by 145% in Q1 2024, buying an estimated $387K and bringing the position to 8,800 shares worth $686K. The position accounts for 0.01% of the portfolio, ranked #1398.

Cetera Advisors first reported a position in HOLX in Q1 2015 and has held it in 9 quarters since. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Cetera Advisors held 8,800 shares of Hologic worth $686K as of Q1 2024.
  • Cetera Advisors bought 5,205 Hologic shares in Q1 2024, an estimated $387K.
  • Hologic made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1398 holding.
  • Cetera Advisors first reported a position in Hologic in Q1 2015 and has held it in 9 quarters since.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.